Edition:
United Kingdom

Chr Hansen Holding A/S (CHRH.CO)

CHRH.CO on Copenhagen Stock Exchange

553.00DKK
3:59pm GMT
Change (% chg)

kr.0.50 (+0.09%)
Prev Close
kr.552.50
Open
kr.552.00
Day's High
kr.556.00
Day's Low
kr.548.00
Volume
155,948
Avg. Vol
168,533
52-wk High
kr.586.50
52-wk Low
kr.379.70

Summary

Name Age Since Current Position

Ole Andersen

61 2010 Independent Chairman of the Board

Cees de Jong

56 2013 President, Chief Executive Officer, Member of the Executive Board

Dominique Reiniche

62 2015 Independent Vice Chairman of the Board

Soeren Lonning

40 2015 Chief Financial Officer, Member of the Executive Board

Torsten Steenholt

48 2017 Executive Vice President, Global Operations

Thomas Schaefer

54 2017 Executive Vice President, Chief Scientific Officer, Member of the Executive Board

Christian Barker

47 2013 Executive Vice President, Health & Nutrition

Joergen Erichsen

55 2015 Executive Vice President, Natural Colors

Sten Estrup

48 2016 Executive Vice President of the Asia-Pacific and Latin American regions

Christoffer Lorenzen

41 2016 Executive Vice President, Food Cultures & Enzymes

Jacob Vishof Paulsen

41 2016 Executive Vice President of the European, Middle Eastern, African & North American regions

Winnie Bugel

52 2016 Corporate Vice President, Compliance, Corporate Communications & Sustainability

Alice Larsen

49 2016 Corporate Vice President, Human Resources

Erik Norstrom

43 2015 Corporate Vice President, Strategic & Business Development

Jesper Brandgaard

54 2017 Director

Lisbeth Grubov

2017 Director, Employee Representative

Charlotte Hemmingsen

2017 Director, Employee Representative

Heidi Kleinbach-Sauter

2017 Director

Per Poulsen

51 2013 Director, Employee Representative

Kim Soerensen

2017 Director, Employee Representative

Luis Cantarell

65 2016 Independent Director

Kristian Villumsen

47 2014 Independent Director

Mark Wilson

65 2010 Independent Director

Martin Riise

2017 Head of Investor Relations

Biographies

Name Description

Ole Andersen

Mr. Ole Andersen has served as Independent Chairman of the Board of Directors at Chr Hansen Holding A/S since February 2010. He is Chairman of the Company's Remuneration and Nomination Committees, and Member of the Company's Audit Committee. He is also Chairman of the Board of Directors at Danske Bank A/S, Bang & Olufsen A/S and one group company, as well as Member of DenmarkBridge, Human Practice Foundation, the Nomination Committee of NASDAQ Nordic Ltd. and the Danish Committee on Corporate Governance. He also serves as Adjunct Professor at Copenhagen Business School. He has experience in managing and developing international companies. He is experienced within financial and accounting matters. Previously, he also served as Chairman of the Board of Directors at Thava-Hamlet Billed-Diagnostisk Center A/S, EQT Investors Holding A/S (company dissolved by merger), EQT Investors I A/S (company dissolved by merger), Contex A/S, Thava-Hamlet-Scanray A/S, Privathospitalet Hamlet A/S and Hamlet Trading ApS; as Member of the Board of Directors at Koebenhavns Lufthavne A/S, DAKO Denmark A/S, DAKO A/S, ISS Management A/S (company dissolved by merger), ISS Global A/S, ISS Holding France A/S, BTX Group A/S, EQT Partners A/S, Holdingselskabet af 24. februar 2006 A/S, Aleris AB, BCT Holding Corp., Georg Jensen A/S and Contex Holding A/S (company dissolved by merger), and he has been Managing Director of CBTJ ApS. He has also held managerial positions at EQT Partners A/S. He holds a Master of Science degree in Business Economics and Auditing.

Cees de Jong

Mr. Cees de Jong has been President, Chief Executive Officer and Member of the Executive Board of Chr Hansen Holding A/S since April 1, 2013. He is to leave the Company soon. He is Doctor of Medicine from the Erasmus University in Rotterdam combined with Master of Business Administration degree from the Rotterdam School of Management, Erasmus University. His professional career started in 1989 with Gist-Brocades (the Netherlands), where he held different positions including Managing Director for the Industrial Pharmaceutical division. Following Gist-Brocades' acquisition by DSM in 1998, he was appointed President of the Anti-Infectives division of DSM. In 2000, he joined Campina as President for the Industrial Products Division, and from 2003 to 2007, he worked for Quest International as Group Vice President and Head of the Flavor division. In 2007, he joined Crucell, and as Chief Operating Officer, he led the company through a transformation process to become a fully integrated biopharmaceutical company until 2011 when it was acquired by Johnson & Johnson. He is Non-Executive Director on the Supervisory Board of ForFarmers N.V.

Dominique Reiniche

Ms. Dominique Reinche has been Independent Vice Chairman of the Board of Directors of Chr Hansen Holding A/S since 2015. She has been Independent Director of the Company since November 26, 2013. She is Member of the Nomination, Remuneration and Scientific Committees of the Company. She serves on the Board of Directors of PayPal Luxembourg and is Chair of its Remuneration and Audit Committees. She also serves at Mondi plc and as member of the Nomination, Remuneration and Sustainability Committees and Severn Trent plc as member of the Sustainability and Nomination Committees. Since 1978, Ms. Reiniche has held positions in the food, beverages and hygiene/beauty care industries in among others Procter & Gamble and Jacobs-Suchard. From 1992 and onwards, Ms. Reiniche has held senior leadership positions within The Coca-Cola Company for 22 years. Ms. Reiniche holds a Master of Business Administration degree from ESSEC Business School, Paris, France.

Soeren Lonning

Mr. Soeren Westh Lonning has been appointed Chief Financial Officer and Member of the Executive Board of Chr. Hansen Holdings A/S, effective as of August 1, 2015. He has served as Managing Director with responsibility for South West Europe and Vice President Finance for the EMEA region at Chr. Hansen. In the period 2007-2013, he held positions as Vice President for Business Finance and Sourcing, Finance Director for the Cultures & Enzymes and Health & Nutrition Divisions, and Director of Corporate Development at Chr. Hansen. Before joining Chr. Hansen, he was Investment Manager at Axcel Private Equity and, prior to that, an Associate at McKinsey & Co. He is CEO and sole shareholder of MNGT4 SWL ApS. He holds a Master of Science in Finance and Accounting (cand.merc.fir.) from Copenhagen Business School (2002).

Torsten Steenholt

Mr. Torsten Steenholt has been Executive Vice President, Global Operations at Chr. Hansen Holding A/S since March 2017. Torsten Steenholt joined Chr. Hansen October 2012 as SVP for Product Supply. Prior to joining Chr. Hansen, Mr. Steenholt was VP Production for Carlsberg Denmark A/S where he served for 3 years. Before this he worked 3 years in Portugal as COO for Unicer SGPS, Portugals leading beverage company. From 2003-2007 he worked in Northampton, UK, as head of Production for Carlsberg UK Ltd. He holds M.Sc. in Pharmacy from the Royal Danish School of Pharmacy (now Copenhagen University); M.Sc. in Chemical Research from University College London and Diploma Master Brewer from the Scandinavian School of Brewing.

Thomas Schaefer

Mr. Thomas Schaefer has been Executive Vice President, Chief Scientific Officer and Member of the Executive Board at Chr. Hansen Holding A/S since November 2017. He holds Ph.D. in Microbiology from Freie Universitaet Berlin, Germany. He has 23 years of experience from Novozymes. As a German national, Thomas Schaefer’s professional career started in 1994 where he joined the enzyme division of Novo Nordisk (in 2000 split into Novozymes) in Microbial Screening as a PostDoc. Throughout his years in Novozymes, he has held various senior positions primarily within R&D and Business Development. In 2013 Thomas Schaefer played a key role in making the BioAg Alliance with Monsanto a reality. This led to three years of expatriation in North Carolina, US, where he established Novozymes’ BioAg Application Research unit in RTP. Thomas Schaefer’s experience spans across both bacteria and enzymes under the umbrella of which he is further the co-inventor on a number of patents as well as publisher of several scientific papers and publications with WWF, WEF and the German Bioeconomy council.

Christian Barker

Mr. Christian Barker has served as Executive Vice President, Health & Nutrition at CHR. HANSEN HOLDING A/S since August 2013. Christian Barker joined Chr. Hansen on May 2, 2012, as head of a Corporate Strategic Development function reporting to the CEO. Prior to joining Chr. Hansen, Mr. Barker was a partner at McKinsey & Company, where he spent 15 years serving global clients on a range of topics including growth strategy, M&A, business building, and restructuring. Mr. Barker joined McKinsey in Copenhagen in 1996, worked for McKinsey in London and Buenos Aires, and was based in New York/New Jersey from 1999 to 2010 before returning to Copenhagen. Mr. Barker holds a Master of Science in Economics and Business Administration from Copenhagen Business School (1996).

Joergen Erichsen

Mr. Joergen M. Erichsen has been appointed Executive Vice President, Natural Colors at CHR. HANSEN HOLDING A/S effective as of July 1, 2015. Prior to joining Chr. Hansen, Mr. Erichsen was Vice President Sales & Marketing at Logitech Int. and a member of Logitech's Global operating committee, where he spent 3 years heading up Logitech's commercial operations in EMEA, based in Switzerland. Prior to Logitech Mr. Erichsen spent 12 years with Colgate Palmolive in various commercial leadership and general management positions in Denmark, UK, Czech Republic and the US in their Hill's Pet Nutrition division - including 5 years as Vice President & Managing Director for EMEA. Prior to Colgate Palmolive, Mr. Erichsen has held leadership positions with Procter & Gamble, Mc Cann-Erickson and Pepsico. Mr. Erichsen holds a Bachelor of Science from Copenhagen Business School (1984) and an Executive MBA from Tuck School of Business (2006).

Sten Estrup

Mr. Sten Estrup has served as Executive Vice President of the Asia-Pacific and Latin American regions at Chr. Hansen Holding A/S since April 2016. He has previously been Group Vice President APAC at the Company since July 2013. Sten Estrup joined Chr. Hansen on January 1, 2002 as International Sales Manager, South America. He spent the next eight years in managerial positions in South and Central America latest as Regional Vice President, South America. In 2010 he returned to Denmark to take up the position as Senior Vice President Commercial Development, Cultures & Enzymes Division. Sten Estrup holds a Master of Science in Dairy Science & Technology and MBA in General Management from Henley Business School (University of Reading).

Christoffer Lorenzen

Mr. Christoffer Lorenzen has been Executive Vice President, Food Cultures & Enzymes at CHR. HANSEN HOLDING A/S since 2016. He holds Master in Business (Marketing), 2002 from the Copenhagen Business School. Christoffer Lorenzen joined Chr. Hansen in March 2008 and has held various positions in Sales and Marketing, including Director and Head of Marketing in our Animal Health & Nutrition Business, and VP and Head of Central & Eastern Europe. In 2013 Mr. Lorenzen was appointed SVP and Head of Commercial Development in the Cultures and Enzymes Division and in 2016 he was appointed EVP and Head of the Food Cultures and Enzymes Business Unit. Prior to joining Chr. Hansen, Mr. Lorenzen was employed at H. Lundbeck A/S, a global specialty pharmaceutical company, where he served as Head of Corporate Strategy and M&A as well as Corporate Secretary.

Jacob Vishof Paulsen

Mr. Jacob Vishof Paulsen has served as Executive Vice President of the European, Middle Eastern, African & North American regions at Chr. Hansen Holding A/S since 2016. He has previously been Group Vice President EMEA at the Company since 2013. Jacob Vishof Paulsen joined Chr. Hansen on October 1, 2006 as Sales & Business Development Director in Global Sales. He was later appointed Area Country Manager for Central East Europe and also spent one year at the Chr. Hansen office in Parma, Italy. From April 2011 he was the Regional Vice President for Europe. He holds Master of Science in Applied Economics and Finance from Copenhagen Business School.

Winnie Bugel

Ms. Winnie Bugel has served as Corporate Vice President, Compliance, Corporate Communications & Sustainability at Chr. Hansen Holding A/S since June 2016. Before that, she has been General Counsel, Corporate Vice President of Compliance and Quality Assurance at the Company since 2015. She has previously been General Counsel and Corporate Vice President of Compliance at Chr Hansen Holding A/S since 2005. She was Director of Legal and Regulatory Affairs at the Company from 2002 until 2005, and Manager of Legal and Regulatory Affairs between 2000 and 2002. She was also Company Secretary to the Board and Personal Assistant to the Chief Executive Officer at Carl Bro Group A/S, from 1998 to 2000. From 1996 to 1998, she worked for Carl Bro Group A/S as Marketing Manager, and between 1990 and 1996, she was employed by DanRail Consult A/S as Project Coordinator and Marketing Manager. She holds a Master of Arts degree in Law from the University of Copenhagen, and a Bachelor's degree in Commerce and International Trade degree from the Copenhagen Business School.

Alice Larsen

Mrs. Alice Larsen has been Corporate Vice President, Human Resources at Chr. Hansen Holding A/S since 2016. Prior to joining Chr. Hansen, Mrs. Larsen was the founder and owner of the New Day Company – a consulting firm located in Zurich and Copenhagen focusing on organizational transformation and development. Before founding New Day Company, Mrs. Larsen spent 4 years with Barry Callebaut AG as Head of Global Human Resources in Zuerich, Switzerland. Prior to that Mrs. Larsen spent 6 years with Novo Nordisk as Vice President Human Resources Region Europe, Brussels, Belgium/Zuerich, Switzerland and Int’l Human Resource Consultant, Copenhagen, Denmark. She holds Master of Science - Copenhagen Business School and Int’l Business Admin. & Modern Languages; English & Japanese with Major: Intercultural Business Mgt. (1997).

Erik Norstrom

Mr. Erik Norstrom has been Corporate Vice President, Strategic & Business Development at Chr. Hansen Holding A/S since August 2015. Erik Norstrom joined Chr. Hansen coming from a position as Head of Business Development and M&A at Nobel Biocare AG, Zurich, where he was responsible for the full range of business development and M&A activities, including corporate strategy. Prior to that Erik Norstrom was Head of M&A and Alliances at Nobel Biocare, AG, Zurich (2008-2012), and before that he held various positions with F. Hoffmann-La Roche, AG, Basel. He holds Master of Science in Chemical Engineering at Chalmer’s University of Technology, Gothenburg, Sweden (1999).

Jesper Brandgaard

Lisbeth Grubov

Charlotte Hemmingsen

Heidi Kleinbach-Sauter

Per Poulsen

Mr. Per Poulsen has served as Employee Representative on the Board of Directors of Chr Hansen Holding A/S since November 26, 2013. He serves as Senior Technology Specialist at Chr. Hansen A/S.

Kim Soerensen

Luis Cantarell

Mr. Luis Cantarell has been Independent Director at Chr. Hansen Holding A/S since November 29, 2016. He is Chairman of the Scientific Committee. Luis Cantarell serves as Chairman of Froneri Ltd (UK). A leading Ice Cream company present in 22 countries and owned by Nestle SA and PAI Advisors. He is also Board member of Grupo URIACH SL, a family owned pharma company based in Barcelona (Spain), and Member of the Foundation Fundacion Fero (Barcelona-Spain) focused in the field of cancer, promoting the development of innovative scientific solutions. Founded by Prof. Dr. Baselga, Medical Director Memorial Sloan Kettering Cancer Center N.Y. (USA). He has professional global experience within the food and beverage industry and extensive board experience and over 10 years of executive leadership experience within the Nestle group. Mr. Cantarell is a graduate of Universitat de Barcelona, Spain, in Economic Sciences and a graduate of the Program for Executive Development from IMD Switzerland.

Kristian Villumsen

Mr. Kristian Villumsen has been Independent Director at Chr. Hansen Holding A/S since November 27, 2014. He is Member of the Audit Committee. Since July 1, 2014, Kristian Villumsen has served as Executive Vice President of Chronic Care at Coloplast A/S, where from 2008 he held senior leadership positions within Global Marketing and Commercial Excellence, Region Europe, and Emerging Markets. He is member of the boards in eight subsidiaries wholly owned by Coloplast A/S. He has knowledge of the medico and life science industry as well as solid international and managerial experience of both European and emerging markets. Mr. Villumsen holds a Master of Arts in Political Science from Aarhus University, Denmark, and a Master’s in Public Policy from Harvard University, USA.

Mark Wilson

Mr. Mark A. Wilson has served as Independent Member of the Board of Directors at Chr Hansen Holding A/S since November 2010. He is Member of the Company’s Remuneration Committee and Chairman of the Audit Committee. He has experience as international Chief Executive Officer/MD with over 40 years in consumer goods companies and service/B2B industries in Asian, South American, United Kingdom, Irish and international markets. Previously, he worked for Numico Asia Pacific and East Asiatic Co. (EAC), including eight years as President and Chief Executive Officer (CEO) based in Singapore. He has also held various senior positions within SmithKline Beecham Consumer Healthcare, his last as President, Representative Director and Board Member of Consumer Healthcare in Japan. He holds a Bachelor of Science degree in Food and Management Science from the University of London, a Diploma in Marketing and he is Fellow of the Chartered Institute of Marketing in the United Kingdom.

Martin Riise